Acceptability, efficacy and safety of pharmacological interventions for cocaine dependence: an overview of Cochrane reviews

[1]  G. Guyatt,et al.  GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. , 2011, Journal of clinical epidemiology.

[2]  Georgia Salanti,et al.  Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. , 2011, Journal of clinical epidemiology.

[3]  R. Kloner,et al.  Cardiovascular Effects of Cocaine , 2010, Circulation.

[4]  Rita Z. Goldstein,et al.  Methylphenidate Attenuates Limbic Brain Inhibition after Cocaine-Cues Exposure in Cocaine Abusers , 2010, PloS one.

[5]  H. Schmidt,et al.  Cocaine‐induced neuroadaptations in glutamate transmission , 2010, Annals of the New York Academy of Sciences.

[6]  Mark Slifstein,et al.  Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion. , 2009, The American journal of psychiatry.

[7]  R P Mattick,et al.  Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. , 2009, The Cochrane database of systematic reviews.

[8]  Sally Hopewell,et al.  An international survey indicated that unpublished systematic reviews exist. , 2009, Journal of clinical epidemiology.

[9]  C. Toro,et al.  Injecting, Sexual Risk Behaviors and HIV Infection in Young Cocaine and Heroin Users in Spain , 2009, European Addiction Research.

[10]  Dan J Stein,et al.  Toward a Global View of Alcohol, Tobacco, Cannabis, and Cocaine Use: Findings from the WHO World Mental Health Surveys , 2008, PLoS medicine.

[11]  Georgia Salanti,et al.  Evaluation of networks of randomized trials , 2008, Statistical methods in medical research.

[12]  Mark J. Thomas,et al.  Neuroplasticity in the mesolimbic dopamine system and cocaine addiction , 2008, British journal of pharmacology.

[13]  W. Drevets,et al.  Orbitofrontal Cortex Function and Structure in Depression , 2007, Annals of the New York Academy of Sciences.

[14]  C. Roncero,et al.  Efficacy of central nervous system stimulant treatment for cocaine dependence: a systematic review and meta-analysis of randomized controlled clinical trials. , 2007, Addiction.

[15]  M. Davoli,et al.  Changing Pattern of Drug Abuse among Patients Entering Treatment in Lazio, Italy, between 1996 and 2003: Transition from Heroin to Cocaine Use , 2007, European Addiction Research.

[16]  A. Preti.  REVIEW: New developments in the pharmacotherapy of cocaine abuse , 2007, Addiction biology.

[17]  P. Jatlow,et al.  Disulfiram effects on responses to intravenous cocaine administration. , 2007, Drug and alcohol dependence.

[18]  David Moher,et al.  Epidemiology and Reporting Characteristics of Systematic Reviews , 2007, PLoS medicine.

[19]  B. Manns,et al.  The quality of reports of critical care meta-analyses in the Cochrane Database of Systematic Reviews: An independent appraisal* , 2007, Critical care medicine.

[20]  R. C. Pierce,et al.  The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse? , 2006, Neuroscience & Biobehavioral Reviews.

[21]  Antonio Alcaro,et al.  Dopamine β-Hydroxylase Knockout Mice have Alterations in Dopamine Signaling and are Hypersensitive to Cocaine , 2006, Neuropsychopharmacology.

[22]  Michael K Gould,et al.  An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. , 2006, American journal of respiratory and critical care medicine.

[23]  T. Kosten,et al.  Emerging pharmacological strategies in the fight against cocaine addiction , 2006, Expert opinion on emerging drugs.

[24]  M. Filip,et al.  The serotonergic system and its role in cocaine addiction. , 2005, Pharmacological reports : PR.

[25]  A. Bechara.  Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective , 2005, Nature Neuroscience.

[26]  Zoe R. Donaldson,et al.  Effects of dopamine β-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice , 2005, Psychopharmacology.

[27]  N. Volkow,et al.  The neural basis of addiction: a pathology of motivation and choice. , 2005, The American journal of psychiatry.

[28]  F. Vocci,et al.  Pharmacotherapy and other treatments for cocaine abuse and dependence , 2005, Current opinion in psychiatry.

[29]  Alessandro Liberati,et al.  Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional study , 2005, BMJ : British Medical Journal.

[30]  Johan Duflou,et al.  Cocaine-related fatalities in New South Wales, Australia 1993-2002. , 2005, Drug and alcohol dependence.

[31]  C. Konradi,et al.  Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules , 2004, Neuropharmacology.

[32]  G. Guyatt,et al.  Grading quality of evidence and strength of recommendations , 2004, BMJ : British Medical Journal.

[33]  B. Rounsaville,et al.  Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial. , 2004, Archives of general psychiatry.

[34]  P. Vezina,et al.  Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs , 2004, Neuroscience & Biobehavioral Reviews.

[35]  N. Goeders,et al.  The impact of stress on addiction , 2003, European Neuropsychopharmacology.

[36]  P. Jatlow,et al.  Disulfiram facilitates the development and expression of locomotor sensitization to cocaine in rats , 2003, Biological Psychiatry.

[37]  L. Degenhardt,et al.  Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia. , 2003, Drug and alcohol dependence.

[38]  N. Volkow,et al.  The addicted human brain: insights from imaging studies. , 2003, The Journal of clinical investigation.

[39]  J. A. Caylà,et al.  Cambio de los problemas de salud provocados por la cocaína en Cataluña , 2001 .

[40]  P Middleton,et al.  Quality of Cochrane reviews: assessment of sample from 1998 , 2001, BMJ : British Medical Journal.

[41]  D. Kupfer,et al.  Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria , 2001, Biological Psychiatry.

[42]  M. Guazzelli,et al.  Neural correlates of imaginal aggressive behavior assessed by positron emission tomography in healthy subjects. , 2000, The American journal of psychiatry.

[43]  B. Rounsaville,et al.  One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatment. , 2000, Addiction.

[44]  T. George,et al.  Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial , 2000, Biological Psychiatry.

[45]  A R Jadad,et al.  Systematic reviews and meta-analyses on treatment of asthma: critical evaluation , 2000, BMJ : British Medical Journal.

[46]  B. Rounsaville,et al.  Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts. , 2000, Addiction.

[47]  Paul E Kinahan,et al.  PET Measures of Amphetamine-Induced Dopamine Release in Ventral versus Dorsal Striatum , 1999, Neuropsychopharmacology.

[48]  M. Carroll,et al.  Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats , 1999, Psychopharmacology.

[49]  S. Leucht,et al.  Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials , 1999, Schizophrenia Research.

[50]  P. Jatlow,et al.  Disulfiram effects on acute cocaine administration. , 1998, Drug and alcohol dependence.

[51]  K. Carroll,et al.  Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. , 1998, Addiction.

[52]  M. Le Moal,et al.  The role of stress in drug self-administration. , 1998, Trends in pharmacological sciences.

[53]  A. Korszun,et al.  Replacement medication for cocaine dependence: methylphenidate. , 1997, Journal of clinical psychopharmacology.

[54]  R. Hubbard,et al.  Characteristics and pretreatment behaviors of clients entering drug abuse treatment: 1969 to 1993. , 1997, The American journal of drug and alcohol abuse.

[55]  G. Badger,et al.  Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. , 1994, Archives of general psychiatry.

[56]  K. Carroll,et al.  One‐Year Follow‐Up Status of Treatment‐Seeking Cocaine Abusers: Psychopathology and Dependence Severity as Predictors of Outcome , 1993, The Journal of nervous and mental disease.

[57]  G. Di Chiara,et al.  Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[58]  Peter C Gøtzsche,et al.  Industry-supported meta-analyses compared with meta-analyses with non-profit or no support : Differences in methodological quality and conclusions , 2015 .

[59]  Z. Xi,et al.  Agents in Development for the Management of Cocaine Abuse , 2012, Drugs.

[60]  P. Tugwell,et al.  Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. , 2007, BMC medical research methodology.

[61]  Piotr Czapiński,et al.  Mechanisms of action of antiepileptic drugs. , 2005, Current topics in medicinal chemistry.

[62]  G. Koob,et al.  The neurobiology of drug addiction. , 1997, The Journal of neuropsychiatry and clinical neurosciences.

[63]  R. Crosby,et al.  Pharmacotherapeutic interventions for cocaine abuse: present practices and future directions. , 1991, Journal of Addictive Diseases.